• ●Bharat Health Global Expo 2026 is the first edition, held at Bharat Mandapam, New Delhi, bringing pharmaceuticals, medical technology, nutraceuticals and healthcare services onto one export-facing platform; the Services Export Promotion Council is among the bodies driving it.
• ●Medical value travel was valued at about USD 8 billion in the Minister's remarks; 'Heal in India' is the government initiative promoting it, led by the Ministry of Health and Family Welfare with the Ministry of Ayush, supported by the Ayush Visa category created in 2023.
• ●PLI Scheme for Bulk Drugs: Rs 6,940 crore for 2020-21 to 2029-30, Department of Pharmaceuticals, to make critical Key Starting Materials, drug intermediates and Active Pharmaceutical Ingredients in India.
• ●PLI Scheme for Pharmaceuticals: Rs 15,000 crore over six years from 2021, aimed at high-value products such as biopharmaceuticals, complex generics, patented and anti-cancer drugs.
• ●PRIP — Promotion of Research and Innovation in Pharma-MedTech Sector: Rs 5,000 crore under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, including Rs 700 crore for Centres of Excellence at seven NIPERs.
• ●Pradhan Mantri Bhartiya Janaushadhi Pariyojana, launched as the Jan Aushadhi Scheme in 2008 and rebranded in 2016, sells affordable generics through Janaushadhi Kendras and is implemented by the Pharmaceuticals & Medical Devices Bureau of India.
• ●Bulk drug parks are coming up in Andhra Pradesh, Gujarat and Himachal Pradesh, and 100 new industrial parks can carry dedicated pharma and healthcare zones.
• ●On trade: the Minister said nine recent FTAs cover 38 developed countries and a combined GDP of about USD 60 trillion, against USD 10 trillion covered by all FTAs until 2014, with 8 to 10 more agreements under negotiation.

Which scheme of the Department of Pharmaceuticals, with an outlay of Rs 6,940 crore for 2020-21 to 2029-30, promotes domestic manufacture of Key Starting Materials, drug intermediates and Active Pharmaceutical Ingredients?